AB0837 Effects of Vitamin D Therapy on Quality of Life in Patients with fibromyalgia. (15th July 2016)

• Record Type: Journal Article
• Authors: Doğru, A.; Balkarlı, A.; Cobankara, V.; Sahin, M.; Tunc, S.E.
• Is Part Of: Annals of the rheumatic diseases. Volume 75(2016)Supplement 2
• Page Start: 1189
• Page End: 1189
• Publication Date: 2016-07-15
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2016-eular.2673
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background: The role of vitamin D in the etiopathogenesis of fibromyalgia and non-specific musculoskeletal pain is controversial. Objectives: In our study, we aimed to investigate the effect of vitamin D therapy on quality of life in patients with fibromyalgia. Methods: 70 patients diagnosed with fibromyalgia and 65 age-sex match controls were included in the study. Patients were grouped as deficiency (<20 ng/mL), inadequacy (20–30 ng/mL) and sufficient (>30 ng/mL) according to the levels of vitamin D. Vitamin D replacement was performed for patients with deficiencies and inadequacies. Before and after vitamin D therapy, patients filled in the assessment tools. Results: Vitamin D deficiencies and inadequacies were observed in 60% of the patients (n=42). Social function, mental health and vitality areas in patients' quality of life forms were significantly lower in normal vitamin D group compared with low vitamin D group. In scales examined after Vitamin D replacement therapy, statistically significant differences were observed in the fibromyalgia impact questionnaire, Beck depression inventory, VAS and SF-36 compared to pre-treatment. Conclusions: Since, vitamin D deficiency seems to be linked to the pathogenesis of FMS, serum vitamin D levels should be checked routinely as a general health problem and patients should be supplemented. Disclosure of Interest: None declared